Type of sample and Method | Samples no. | Prevalence | 95% CIa | Positive LRb | Negative LR |
---|---|---|---|---|---|
lymph node (N = 54) |  |  |  |  |  |
rpoB sequencing | 39 | 72.22% | 79–95 | 72.95 | 0.90 |
real-time PCR | 33 | 61.11% | 46–59 | 60.01 | 0.82 |
urine(N = 20) |  |  |  |  |  |
rpoB sequencing | 3 | 0.15% | 73–95 | 73.94 | 0.91 |
real-time PCR | 1 | 0.05% | 28–45 | 14.24 | 0.79 |
skin lesion (N = 10) |  |  |  |  |  |
rpoB sequencing | 10 | 100% | 70–95 | 100 | 0.00 |
real-time PCR | 10 | 100% | 70–95 | 100 | 0.00 |
pleural fluid (N = 34) |  |  |  |  |  |
rpoB sequencing | 23 | 67.64% | 69–95 | 79.97 | 0.95 |
real-time PCR | 23 | 67.64% | 33–54 | 79.27 | 0.95 |
bone biopsy(N = 6) |  |  |  |  |  |
rpoB sequencing | 2 | 68.79% | 62–95 | 79.95 | 0.99 |
real-time PCR | - | - | - | - | - |